Who
Kathy Turner V
Director
Company insider
Files Form 4 as: Director, ImmuCell; Director, Elanco Animal Health; Senior Vice President, IDEXX Laboratories.
In numbers
- Trades disclosed
- 124
- Buys
- 0
- Sells
- 15
- Bought
- $0
- Sold
- $17.2M
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 1 Jun 2018
- Last trade
- 15 Apr 2026
- Last filed
- 16 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Apr 2026filed 16 Apr 2026 | ICCC ImmuCelloption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —17,899 at $0.00 | filing |
| 15 Apr 2026filed 16 Apr 2026 | ICCC ImmuCelloption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —17,899 at $0.00 | filing |
| 29 Nov 2024filed 3 Dec 2024 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code A | —13,838 at $0.00 | filing |
| 16 Feb 2023filed 17 Feb 2023 | IDXX IDEXX Laboratoriesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —10 | filing |
| 16 Feb 2023filed 17 Feb 2023 | IDXX IDEXX LaboratoriesDiagnostics & Labs | SEC FORM 4 Code M | $79510 at $79.54 | filing |
| 16 Feb 2023filed 17 Feb 2023 | IDXX IDEXX LaboratoriesDiagnostics & Labs | SEC FORM 4 Sold | $5,15610 at $515.58 | filing |
| 15 Feb 2023filed 17 Feb 2023 | IDXX IDEXX Laboratoriesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —1,000 | filing |
| 15 Feb 2023filed 17 Feb 2023 | IDXX IDEXX LaboratoriesDiagnostics & Labs | SEC FORM 4 Code A | $80K1,000 at $79.54 | filing |
| 15 Feb 2023filed 17 Feb 2023 | IDXX IDEXX LaboratoriesDiagnostics & Labs | SEC FORM 4 Sold | $510K1,000 at $510.03 | filing |
| 14 Feb 2023filed 16 Feb 2023 | IDXX IDEXX Laboratoriesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —210 | filing |
| 14 Feb 2023filed 16 Feb 2023 | IDXX IDEXX Laboratoriesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —181 | filing |
| 14 Feb 2023filed 16 Feb 2023 | IDXX IDEXX Laboratoriesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —162 | filing |
| 14 Feb 2023filed 16 Feb 2023 | IDXX IDEXX Laboratoriesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —86 | filing |
| 14 Feb 2023filed 16 Feb 2023 | IDXX IDEXX Laboratoriesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —93 | filing |
| 14 Feb 2023filed 16 Feb 2023 | IDXX IDEXX Laboratoriesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —2,000 | filing |
| 14 Feb 2023filed 16 Feb 2023 | IDXX IDEXX LaboratoriesDiagnostics & Labs | SEC FORM 4 Code M | —210 at $0.00 | filing |
| 14 Feb 2023filed 16 Feb 2023 | IDXX IDEXX LaboratoriesDiagnostics & Labs | SEC FORM 4 Code M | —181 at $0.00 | filing |
| 14 Feb 2023filed 16 Feb 2023 | IDXX IDEXX LaboratoriesDiagnostics & Labs | SEC FORM 4 Code M | —162 at $0.00 | filing |
| 14 Feb 2023filed 16 Feb 2023 | IDXX IDEXX LaboratoriesDiagnostics & Labs | SEC FORM 4 Code M | —86 at $0.00 | filing |
| 14 Feb 2023filed 16 Feb 2023 | IDXX IDEXX LaboratoriesDiagnostics & Labs | SEC FORM 4 Code M | —93 at $0.00 | filing |
News
IDEXX Laboratories (IDXX) vs. ZTS and NEOG: Can Raised Guidance and Product Expansion Drive Further Earnings Growth?IDXX · insidermonkey.com · 22 Oct 2026
0 headlines in the last 90 days name Kathy Turner V; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.